Medicine/Drugs
-
An Endocrinologist’s Frustration with Insulin Therapy
A diabetes doctor confronts the limits to what she can do to help her patients.
Read More » -
Protesting Ontario Test Strip Restrictions
Columnist Alyssa Tangerine details how a government policy curbing test strip reimbursement can hurt people with diabetes.
Read More » -
Is Glucagon Ready for Primetime?
A pharmaceutical company hints it has created a room-temperature liquid glucagon that performs as well as powdered glucagon.
Read More » -
Insulin Pen Misuse At Hospitals
Thousands of people with diabetes have been exposed to bloodborne pathogens. How can we prevent it?
Read More » -
T1 Diabetes is Complicated…Even for Doctors
Can you name all the hormones needed for good blood glucose control? If not, you’re not alone.
Read More » -
Waiting to Exhale with Afrezza
An FDA panel clears Mannkind’s inhalable insulin to take off, but will Afrezza gain altitude or fall flat?
Read More » -
A Future of Fewer Injections?
Needle fear gets in the way of insulin therapy. Will Medtronic’s i-port provide relief from being a pincushion?
Read More » -
Skin Drug Reduces Need for Insulin
Researchers find alefacept helps people with T1 diabetes maintain insulin production.
Read More » -
Unlocking the Basal Mystery
We all know about bolus, but do you know how basal insulin works? Here’s the inside story.
Read More » -
-
Daily Pill May Help T1s Lower A1c and Reduce Insulin Use
A new study finds dapagliflozin might help lower A1c levels when insulin alone isn’t cutting it.
Read More » -
Uncovering a Pancreatic Bodyguard
Researchers have discovered a rare immune system cell that might shield the pancreas from attack in models of mice with Type 1 diabetes.
Read More » -
Google Plus Oral Insulin?
Google Ventures is investing in a California startup that wants to make injectable drugs an easier pill to swallow.
Read More » -
Back to the Future for Cancer Drug That May Help Type 1s
An old drug used to treat cancerous tumors may help suppress the immune system destruction that causes Type 1 diabetes.
Read More » -
Medicare Needs to Do More to Cut Test Strip Overbilling
The Medicare program needs to do more to prevent questionable billing for diabetes test strips, according to a new report. An audit of billing practices by the Centers for Medicare and Medicaid Services found that the agency had doled out…
Read More » -
Afrezza Enters the Home Stretch…Again
Could a new insulin inhaler be approved for 2014? An FDA decision on Afrezza is expected in the coming months.
Read More » -
The Connection Between Glowing Bunnies and Diabetes Research
Researchers have spliced a jellyfish gene into rabbit DNA to make glow-in-the-dark bunnies. It’s an advance that has implications for diabetes research down the road.
Read More » -
Court Rules in Favor of California Schools on Insulin Shots
Children with diabetes in California will have an easier time getting insulin injections at school this fall, thanks to a new court ruling.
Read More » -
Zombie Drug May Help Type 1 Kids
Researchers have found promise in a Type 1 diabetes drug that was left for dead in 2010.
Read More » -
Glaxo Settles with States on Avandia
GlaxoSmithKline agrees to pay $229 million to nine states to settle claims over Avandia, its once-popular diabetes drug. At the same time, the FDA loosens restrictions on the drug.
Read More »
